TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/20/23 18:09 | 12/18/23 | PNT | Point Biopharma Global Inc. | DE | Financ | InvAdv | Investment Advice | Bvf Partners L P/Il | CA | H | Former 1 | S | -213,658 | 12.45 | 0 | -17,161 | -100 | 0 | D | ||||||||||||||
8/11/22 17:52 | 8/9/22 | CTIC | Cti Biopharma Corp | DE | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | DTH | See Rema | S.d | -52,020 | 6.12 | 0 | -8,500 | -79 | 2,272 | M | ||||||||||||||
10/8/21 21:24 | 10/7/21 | MRUS | Merus N.V. | DE | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | T | S.m | -31,222 | 27.56 | 0 | -1,133 | -83 | 233 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |